In November 2017, Asana Medical, Inc. announced that they had formally changed their name to Regentys, as a more distinctive representation of their business model and underlying regenerative medicine technology.

Generex Biotechnology Partner Regentys Corporation Receives European Patent Approval for ECMH™ for Treatment of Ulcerative Colitis

Dec. 14, 2018

Generex Biotechnology Corporation (OTCQB:GNBT) announced today that Regentys Corporation (formerly Asana Medical, Inc.), a clinical stage regenerative medicine company contracted to become a subsidiary of Generex, was granted European Patent No. 2983616 entitled “Method And Composition For Treating Inflammatory Bowel Disease Without Colectomy.”

Read More →

Generex Biotechnology Expands Medical Device & Wound Care Portfolio with Acquisition of Regentys Corporation

Nov. 29, 2018

Generex Biotechnology Corporation (OTCMKTS:GNBT) is pleased to announce that the company has signed a Binding Letter of Intent to acquire 51% of Regentys Corporation, a regenerative medicine company focused on developing treatments for patients with gastrointestinal (GI) disorders.

Read More →

Regentys Named Finalist!

June 28, 2018

Lyfebulb LLC and UnitedHealth Group (NYSE:UNH) have selected 11 Patient Entrepreneur finalists who will compete in the “Empowering Patients: An Innovation Challenge” to earn the Lyfebulb and UnitedHealth Group Innovation Award.

Read More →

Regentys, Cook Biotech to Collaborate in Developing, Delivering Unique Ulcerative Colitis Treatment

Feb. 14, 2018

Regentys (formerly Asana Medical, Inc.), a regenerative medicine company, today announced it will partner with Cook Biotech Inc., a world leader in cost-effective, advanced tissue-repair products, to develop a novel treatment for ulcerative colitis.

Read More →

Regentys Names Dr. John F. Howes Vice President of Clinical and Regulatory Affairs

Jan. 9, 2018

Company Continues to Add Distinguished Medical Experts as Focus Pivots to First-In-Human Clinical Trials of its Novel, Regenerative Medicine Solution for Ulcerative Colitis.

Read More →